NCT07018726 · RECRUITING

Addressing Emotional Distress in Dyads of Persons With a Young Onset Dementia (YOD) and Their Care-partners

This trial is testing a six-session virtual program called Resilient Together-YOD for people recently diagnosed with young-onset dementia and their care-partners. Both attend sessions together. The goal is to reduce emotional distress and build resilience in both people — not to slow dementia itself. This is a Phase N/A trial, meaning it is evaluating whether the program works and is acceptable, not testing a drug or device.

You may qualify if

  • Between the ages of 18-65 at the time of enrollment [both patient and care-partner]
  • Diagnosis of young-onset dementia (FTD, PPA, AD, PCA, etc.) with symptom onset prior to age 65 [patient]
  • A designated care-partner willing and interested to participate [both patient and care-partner]
  • Received YOD diagnosis in the past 6 month [patient]
  • English fluency and literacy [both patient and care-partner]
  • Cognitive ability to understand study and research protocol in order to consent to study participation per referring neurologist [both patient and care-partner]
  • Patient and/or caregiver exhibit emotional distress on screening (using HADS D and/or HADS A scores > 7)

You're excluded if

  • An additional, terminal diagnosis such as cancer
  • Lack of access to internet and/or a device with a camera
  • Current untreated or unstable severe mental health conditions like bipolar disorder, schizophrenia, or active substance use

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-02-11

View full record on ClinicalTrials.gov

All APOE4 clinical trials